Axsome Therapeutics, Inc. AXSM announced that the FDA has approved Symbravo (meloxicam and rizatriptan) for the acute ...

Meloxicam is a nonsteroidal, anti-inflammatory molecule developed with Axsome’s Molecular Solubility Enhanced Inclusion ...

Axsome Therapeutics (NASDAQ:AXSM) has received FDA approval for its drug Symbravo for the acute treatment of migraine with or ...

People who live with narcolepsy — about ... GHB and criminally used as a date rape drug — has been sold under the brand name Xyrem after gaining FDA approval in 2002. In order to bring it ...

The FDA expanded the approval of Lumryz extended-release oral suspension for treatment of pediatric narcolepsy. The Food and Drug Administration (FDA) has expanded the approval of Lumryz ...

Shares in Axsome Therapeutics have rocketed on FDA ... approved in March 2019 and is administered as a nasal spray twice a week for four weeks. However, it has a broader label as unlike J&J's drug ...

The amount of people with MDD continues to increase every year. The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment of MDD in those who have not ...

According to GlobalData, Phase I drugs for Narcolepsy have an 80% phase transition success rate (PTSR) indication benchmark for progressing into Phase II. GlobalData’s report assesses how E-2086’s ...

This medication is Food and Drug Administration (FDA)–approved to treat ADHD and narcolepsy (a medical condition characterized by overwhelming daytime drowsiness). Adderall IR is available as a tablet ...

Mazindol ER is under clinical development by NLS Pharmaceutics and currently in Phase II for Type 2 Narcolepsy (Narcolepsy ... data and analytics to create drugs-specific PTSR and LoA in the Mazindol ...

Ozempic is already widely used and was first FDA-approved in 2017 to treat type 2 diabetes. The medication — taken weekly by injection in the thigh, stomach or arm — is a brand name for ...

A cannabinoid drug candidate for the treatment of Autism Spectrum Disorder is being explored by in ... [+] trials, led by Ajna BioSciences, Charlotte's Web, and British-American Tobacco in a joint ...